Endorsed NICE Technology Appraisals 2009/2010

Topics:

Date published: 20 November 2009

Endorsed NICE Technology Appraisals 2009/2010

The following NICE Technology Appraisals were endorsed by DoH during 2009-10

Documents

National Institute for Health and Clinical Excellence (NICE) Technology Appraisal TA151 - Diabetes - Insulin Pump Therapy - HSC (SQSD) (NICE) 29/2009Adobe PDF (386.69 KB)
National Institute for Health and Clinical Excellence (NICE) Technology Appraisal TA152 - Coronary Artery Disease - Drug Eluting Stents - HSC (SQSD) 30/2009Adobe PDF (372.77 KB)
National Institute for Health and Clinical Excellence (NICE) Technology Appraisal TA153 - Entecavir for the Treatment of Chronic Hepatitis B - HSC (SQSD) (NICE) 39/2009Adobe PDF (349.28 KB)
National Institute for Health and Clinical Excellence (NICE) Technology Appraisal TA154 - Telbivudine for the Treatment of Chronic Hepatitis B - HSC (SQSD) (NICE) 40/2009Adobe PDF (349.02 KB)
National Institute for Health and Clinical Excellence (NICE) Technology Appraisal TA157 - Venous Thromboembolism - Dabigatran - HSC (SQSD) (NICE) 31/2009Adobe PDF (360.29 KB)
National Institute for Health and Clinical Excellence (NICE) Technology Appraisal TA158 - Amantadine, Oseltamivir and Zanamivir for Influenza Prophylaxis - HSC (SQSD) (NICE) 41/2009Adobe PDF (365.17 KB)
National Institute for Health and Clinical Excellence (NICE) Technology Appraisal TA160 - Osteoporosis - Primary Prevention - HSC (SQSD) (NICE) 32/2009Adobe PDF (366.01 KB)
National Institute for Health and Clinical Excellence (NICE) Technology Appraisal TA161 - Osteoporosis - Secondary Prevention Including Strontium Ranelate - HSC (SQSD) (NICE) 33/2009Adobe PDF (367.3 KB)
National Institute for Health and Clinical Excellence (NICE) Technology Appraisal TA163 - Infliximab for Acute Exacerbations of Ulcerative Colitis - HSC (SQSD) (NICE) 42/2009Adobe PDF (348.47 KB)
National Institute for Health and Clinical Excellence (NICE) Technology Appraisal TA164 - Febuxostat for the Treatment of Hyperuricaemia in People with Gout - HSC (SQSD) (NICE) 46/2009Adobe PDF (347.36 KB)
National Institute for Health and Clinical Excellence (NICE) Technology Appraisal TA165 - Machine Perfusion Systems and Cold Static Storage of Kidneys from Deceased Donors - HSC (SQSD) (NICE) 43/2009Adobe PDF (350.02 KB)
National Institute for Health and Clinical Excellence (NICE) Technology Appraisal TA167 - Endovascular Stent Grafts for the Treatment of Abdominal Aortic Aneurysms - HSC (SQSD) (NICE) 47/2009Adobe PDF (352.75 KB)
National Institute for Health and Clinical Excellence (NICE) Technology Appraisal TA168 - Amantadine, Oseltamivir and Zanamivir for the Treatment of Influenza (review of TA58) - HSC (SQSD) (NICE) 44/2009Adobe PDF (369.81 KB)
National Institute for Health and Clinical Excellence (NICE) Technology Appraisal TA170 - Rivaroxaban for the Prevention of Venous Thromboembolism after Total Hip or Total Knee Replacement in Adults - HSC (SQSD) (NICE) 48/2009Adobe PDF (342.88 KB)
National Institute for Health and Clinical Excellence (NICE) Technology Appraisal TA173 - Hepatitis B - Tenofovir Disoproxil Fumarate - HSC (SQSD) (NICE) 66/2009Adobe PDF (342.83 KB)
National Institute for Health and Clinical Excellence (NICE) Technology Appraisal TA174 - Leukaemia (chronic lymphocytic) Rituximab - HSC (SQSD) (NICE) 67/2009Adobe PDF (347.4 KB)